CRISPR Therapeutics to Speak at Bank of America Health Conference

CRISPR Therapeutics, a biopharmaceutical company known for developing gene-based medicines for serious diseases, has announced that its senior management team will present at the Bank of America Securities Health Care Conference. This presentation is scheduled for Wednesday, May 15, 2024, at 12:20 p.m. ET. A live webcast of the discussion will be accessible on the "Events & Presentations" page in the Investors section of the company's website. Additionally, the webcast will be available for replay on the company's site for 14 days after the event.

CRISPR Therapeutics, founded over a decade ago, has made significant strides in the field of gene editing. Initially a research-focused entity, the company recently achieved a major milestone with the approval of the first CRISPR-based therapy. Its product pipeline includes candidates targeting a wide array of diseases, such as hemoglobinopathies, cancer, regenerative medicine, cardiovascular conditions, autoimmune disorders, and rare diseases.

In 2018, CRISPR Therapeutics pioneered the first clinical trial involving CRISPR/Cas9 gene-edited therapy. This trial aimed to treat patients with sickle cell disease or transfusion-dependent beta thalassemia. By late 2023, CASGEVY™ (exagamglogene autotemcel) received approval in certain countries for treating eligible patients with these conditions.

The revolutionary CRISPR technology, which earned a Nobel Prize, has had a profound impact on biomedical research. It offers a validated, powerful approach that could lead to a new class of transformative medicines. To further its mission, CRISPR Therapeutics has formed strategic partnerships with prominent companies like Bayer and Vertex Pharmaceuticals.

CRISPR Therapeutics AG is headquartered in Zug, Switzerland. Its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., conducts research and development operations in Boston, Massachusetts, and San Francisco, California. The company also has business offices in London, United Kingdom.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!